Mortality associated with new risk classification of developing refeeding syndrome in critically ill patients: A cohort study

医学 重症监护室 死亡风险 急诊医学 比例危险模型 危险系数 队列研究 弗雷明翰风险评分 风险评估 内科学 队列 病危 重症监护医学 儿科 疾病 置信区间 计算机科学 计算机安全
作者
Minoru Yoshida,Junichi Izawa,Haruaki Wakatake,Hiroki Saito,Chizu Kawabata,Shinya Matsushima,Aya Suzuki,Akiyoshi Nagatomi,Toru Yoshida,Yoshihiro Masui,Shigeki Fujitani
出处
期刊:Clinical Nutrition [Elsevier BV]
卷期号:40 (3): 1207-1213 被引量:32
标识
DOI:10.1016/j.clnu.2020.07.034
摘要

SummaryBackground & aimsAlthough refeeding syndrome (RFS) has been recognized as a potentially fatal metabolic complication, the definition of RFS has remained unclear. Recently, European researchers suggested an evidence-based and consensus-supported algorithm that consisted of a new RFS risk classification and treatment strategies for medical inpatients. The classification was based on the National Institute for Health and Clinical Excellence (NICE) criteria for patients at risk of developing RFS. In this study, we aimed to investigate the frequency of each applied new risk group and the association between the new classification and mortality in critically ill patients.MethodsThis cohort study was conducted at a Japanese metropolitan tertiary-care university hospital from December 2016 to December 2018. We included critically ill adult patients who were admitted to the intensive care unit (ICU) via the emergency department and who stayed in the ICU for 24 h or longer. We applied the new risk classification based on the NICE RFS risk factors on ICU admission. The main exposure was risk classification of RFS: no risk, low risk, high risk, or very high risk. The primary outcome was in-hospital mortality censored at day 30 after ICU admission. We performed a multivariable analysis using Cox proportional hazard regression.ResultsWe analyzed 542 patients who met the eligibility criteria. The prevalence of the four RFS risk classification groups was 25.8% for no risk, 25.7% for low risk, 46.5% for high risk, and 2.0% for very high risk. The 30-day mortality was 5.0%, 7.2%, 16.3%, and 27.3%, respectively (log-rank trend test: p < 0.001). In the multivariable Cox regression, adjusted hazard ratios with no risk group as a reference were 1.28 (95% CI 0.48–3.38) for low risk, 2.81 (95% CI 1.24–6.35) for high risk, and 3.17 (95% CI 0.78–12.91) for very high risk.ConclusionsApproximately half the critically ill patients were categorized as high or very high risk based on the new risk classification. Furthermore, as the risk categories progressed, the 30-day in-hospital mortality increased. Early recognition of patients at risk of developing RFS may improve patient outcomes through timely and optimal nutritional treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Omni完成签到,获得积分10
1秒前
Tmac完成签到 ,获得积分10
4秒前
邵邵完成签到,获得积分10
6秒前
zw完成签到 ,获得积分10
6秒前
南村群童完成签到 ,获得积分10
8秒前
Hua完成签到,获得积分10
10秒前
满意的灵枫完成签到 ,获得积分10
11秒前
666完成签到 ,获得积分10
14秒前
mhy完成签到 ,获得积分10
14秒前
cloudehbh完成签到 ,获得积分10
17秒前
张笨笨完成签到 ,获得积分10
18秒前
Zoe完成签到,获得积分10
18秒前
木子完成签到 ,获得积分10
19秒前
活力的鹰完成签到 ,获得积分10
19秒前
乐空思的应助被李麟采纳,获得100
20秒前
嘻嘻哈哈的应助被李麟采纳,获得10
20秒前
22秒前
savesunshine1022完成签到,获得积分10
22秒前
wzk完成签到,获得积分10
23秒前
BAEK完成签到,获得积分10
24秒前
LaixS完成签到,获得积分0
26秒前
敏静发布了新的文献求助10
26秒前
感动的天德完成签到,获得积分10
26秒前
梅梅完成签到 ,获得积分10
27秒前
tt完成签到,获得积分10
28秒前
要笑cc完成签到,获得积分0
28秒前
大熊完成签到 ,获得积分10
28秒前
8D完成签到,获得积分10
28秒前
宣宣宣0733完成签到,获得积分0
30秒前
乖咪甜球球完成签到 ,获得积分10
31秒前
俏皮的莫言完成签到,获得积分10
31秒前
胡质斌完成签到,获得积分0
32秒前
薯片完成签到 ,获得积分10
33秒前
敏静完成签到,获得积分10
36秒前
高妍纯完成签到 ,获得积分10
39秒前
口口完成签到,获得积分20
40秒前
46秒前
xlll完成签到,获得积分10
48秒前
江安弘完成签到,获得积分10
49秒前
000001完成签到,获得积分10
49秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185520
求助须知:如何正确求助?哪些是违规求助? 9574253
关于积分的说明 21834609
捐赠科研通 7783129
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558951
邀请新用户注册赠送积分活动 2481357